2010 position paper of the Italian Society of Hypertension (SIIA): Angiotensin receptor blockers and risk of cancer

High Blood Pressure and Cardiovascular Prevention

Volumn 18, Issue 1, 2011, Pages 37-40

  Volpe, Massimo ^a,b   Morganti, Alberto ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

ACE inhibitors; Angiotensin receptor blockers; cancer; cancer risk; mortality; renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTINEOPLASTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO; VALSARTAN;

ANGIOGENESIS; ANTIHYPERTENSIVE THERAPY; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CARCINOGENESIS; COMPARATIVE STUDY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG USE; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERTENSION; LUNG CANCER; META ANALYSIS (TOPIC); METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; TREATMENT INDICATION;

ANGIOTENSIN RECEPTOR ANTAGONISTS; CONSENSUS; HUMANS; HYPERTENSION; ITALY; NEOPLASMS; RISK ASSESSMENT; SOCIETIES, MEDICAL;

EID: 79955601757     PISSN: 11209879     EISSN: 11791985     Source Type: Journal    
DOI: 10.2165/11588060-000000000-00000     Document Type: Article

References (25)

1. Corrao G, Zambon A, Parodi A, et al. Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy. J Hypertens 2008 Apr; 26 (4): 819-24 (Pubitemid 351354932)
2. Volpe M, Azizi M, Danser AH, et al. Twisting arms to angiotensin receptor blockers/antagonists: the turn of cancer. Eur Heart J 2011 Jan; 32 (1): 19-22
3. Volpe M, Tocci G, Pagannone E. Fewer mega-trials and more clinically oriented studies in hypertension research? The case of blocking the reninangiotensin- aldosterone system. J Am Soc Nephrol 2006 Apr; 17 (4 Suppl. 2): S36-43
4. Mancia G, De Backer G, Dominiczak A, et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007 Sep; 25 (9): 1751-62 (Pubitemid 47356612)
5. Verma S, Strauss M. Angiotensin receptor blockers and myocardial infarction. BMJ 2004 Nov 27; 329 (7477): 1248-9 (Pubitemid 39582781)
6. Volpe M, Tocci G, Sciarretta S, et al. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials. J Hypertens 2009 May; 27 (5): 941-6
7. Pfeffer MA, Swedberg K, Granger CB, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARMOverall programme. Lancet 2003 Sep 6; 362 (9386): 759-66 (Pubitemid 37093915)
8. Sipahi I, Debanne SM, Rowland DY, et al. Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials. Lancet Oncol 2010 Jul; 11 (7): 627-36
9. Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: theVALUE randomised trial. Lancet 2004 Jun 19; 363 (9426): 2022-31 (Pubitemid 38781102)
10. The ARB Trialists Collaboration. Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals. J Hypertens 2011 Apr; 29 (4): 623-35
11. Doi C, Egashira N, Kawabata A, et al. Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice. BMC Cancer 2010; 10: 67
12. Pickel L, Matsuzuka T, Doi C, et al. Overexpression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells. Cancer Biol Ther. Epub 2010 Feb 16
13. Moltzer E, Verkuil AV, van Veghel R, et al. Effects of angiotensin metabolites in the coronary vascular bed of the spontaneously hypertensive rat: loss of angiotensin II type 2 receptor-mediated vasodilation. Hypertension 2010 Feb; 55 (2): 516-22
14. Azizi M, Junot C, Ezan E, et al. Angiotensin I-converting enzyme and metabolism of the haematological peptide N-acetyl-seryl-aspartyl-lysyl-proline. Clin Exp Pharmacol Physiol 2001 Dec; 28 (12): 1066-9 (Pubitemid 34053525)
15. Liu JM, KusinskiM, Ilic V, et al. Overexpression of the angiogenic tetrapeptide AcSDKP in humanmalignant tumors. Anticancer Res 2008 Sep-Oct; 28 (5A): 2813-7
16. Cruciat CM, Ohkawara B, Acebron SP, et al. Requirement of prorenin receptor and vacuolar H+-ATPase-mediated acidification for Wnt signaling. Science 2010 Jan 22; 327 (5964): 459-63
17. Lever AF, Hole DJ, Gillis CR, et al. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 1998 Jul 18; 352 (9123): 179-84 (Pubitemid 28327802)
18. Les L. ACE inhibitors may reduce esophageal cancer incidence. Gastroenterology 2006; 131 (2): 343-4
19. Wilop S, von Hobe S, Crysandt M, et al. Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum- based chemotherapy. J Cancer Res Clin Oncol 2009 Oct; 135 (10): 1429-35
20. Heinzerling JH, Anthony T, Livingston EH, et al. Predictors of distant metastasis and mortality in patients with stage II colorectal cancer. Am Surg 2007 Mar; 73 (3): 230-8 (Pubitemid 351396700)
21. UemuraH,HasumiH,Kawahara T, et al. Pilot study of angiotensin II receptor blocker in advanced hormone-refractory prostate cancer. Int J Clin Oncol 2005 Dec; 10 (6): 405-10 (Pubitemid 41821524)
22. Egami K, Murohara T, Shimada T, et al. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 2003 Jul; 112 (1): 67-75 (Pubitemid 38056377)
23. Fujita M, Hayashi I, Yamashina S, et al. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Carcinogenesis 2005 Feb; 26 (2): 271-9 (Pubitemid 40253497)
24. Neo JH, Malcontenti-Wilson C,Muralidharan V, et al. Effect ofACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases. J Gastroenterol Hepatol 2007 Apr; 22 (4): 577-84 (Pubitemid 46434989)
25. Bangalore S, Kumar S, Kjeldsen SE, et al. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. Lancet Oncol 2011; 12 (1): 6-8